RENNIE

This brand name is authorized in Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, Romania, Singapore, Turkey, South Africa

Active ingredients

The drug RENNIE contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcium carbonate
UNII H0G9379FGK - CALCIUM CARBONATE

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement.

Read about Calcium carbonate
2 Magnesium carbonate
UNII 0E53J927NA - MAGNESIUM CARBONATE

Magnesium carbonate, MgCO3 (archaic name magnesia alba), is an inorganic salt. The most common magnesium carbonate forms are the anhydrous salt called magnesite (MgCO3) and the di, tri, and pentahydrates known as barringtonite (MgCO3·2 H2O), nesquehonite (MgCO3·3 H2O), and lansfordite (MgCO3·5 H2O), respectively. The primary use of magnesium carbonate is the production of magnesium oxide by calcining.

Read about Magnesium carbonate

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RENNIE PEPPERMINT Chewable tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A02AD01 Ordinary salt combinations A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AD Combinations and complexes of aluminium, calcium and magnesium compounds
Discover more medicines within A02AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1001002, 1824522, 1824533, 1824544, 1824555, 1824566, 1824577, 1824588, 1824599, 1824601, 1824612
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 52873, 62940
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 006716, 057279, 095272, 109264, 109280, 158323, 393633, 451340
Country: FR Base de données publique des médicaments Identifier(s): 65323026, 67897322, 69628395
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-197674944
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 1313, 1314, 5419, 5420
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1006992
Country: MT Medicines Authority Identifier(s): MA639/01101, MA639/01104, MA639/01105, PI1438/09501A, PI1438/09502A
Country: NL Z-Index G-Standaard, PRK Identifier(s): 18724, 86592, 88854, 98868
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W51391003, W51392001
Country: SG Health Sciences Authority Identifier(s): 08733P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699546085767, 8699546705757
Country: ZA Health Products Regulatory Authority Identifier(s): 46/11.4.1/0517

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.